PD-L1 Immunohistochemistry Comparability and Their Correlation with Clinical Characteristics in NSCLC

BACKGROUND: PD-L1 expression is an important predictive factor of response to therapy with immune checkpoint inhibitors (ICIs). This study was designed to retrospectively analyze the concordance of PD-L1 measurements using three different assays (Dako22C3, Dako28-8, and SP142) in NSCLC patients and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chiao-En, Chang, Ching-Fu, Kou-Sheng, Liao, Chiang, Ju, Lee, Shih-Wei, Chiu, Yu-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655253/
https://www.ncbi.nlm.nih.gov/pubmed/33204603
http://dx.doi.org/10.1155/2020/3286139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655253/
https://www.ncbi.nlm.nih.gov/pubmed/33204603
http://dx.doi.org/10.1155/2020/3286139

Ejemplares similares